PET-CT in Clinical Adult Oncology: III. Gastrointestinal Malignancies
Open Access
Abstract
PET-CT is an advanced imaging modality with many oncologic applications, including staging, assessment of response to therapy, restaging and longitudinal surveillance for recurrence. The goal of this series of six review articles is to provide practical information to providers and imaging professionals regarding the best use of PET-CT for specific oncologic indications, and the potential pitfalls and nuances that characterize these applications. In the third of these review articles, key tumor-specific clinical information and representative PET-CT images are provided to outline the role that PET-CT plays in the management of patients with gastrointestinal malignancies. The focus is on the use of 18F fluorodeoxyglucose (FDG), rather than on research radiopharmaceuticals under development. Many different types of gastrointestinal tumors exist, both pediatric and adult. A discussion of the role of FDG PET-CT for all of these is beyond the scope of this review. Rather, this article focuses on the most common adult gastrointestinal malignancies that may be encountered in clinical practice. The information provided here will provide information outlining the appropriate role of PET-CT in the clinical management of patients with gastrointestinal malignancies for healthcare professionals caring for adult cancer patients. It also addresses the nuances and provides interpretive guidance related to PET-CT for imaging providers, including radiologists, nuclear medicine physicians and their trainees.Keywords
This publication has 94 references indexed in Scilit:
- PET-Negative Gastrointestinal Stromal TumorsCase Reports in Oncology, 2013
- Metformin-Induced Intense Bowel Uptake Observed on Restaging FDG PET/CT Study in a Patient with Gastric LymphomaMolecular Imaging and Radionuclide Therapy, 2011
- Fluorine-18-fluorodeoxyglucose uptake in a benign oesophageal leiomyoma: a potential pitfall in diagnosisInteractive CardioVascular and Thoracic Surgery, 2011
- Mucin phenotype of gastric cancer and clinicopathology of gastric-type differentiated adenocarcinomaWorld Journal of Gastroenterology, 2010
- Staging investigations for oesophageal cancer: a meta-analysisBritish Journal of Cancer, 2008
- CT and PET: Early Prognostic Indicators of Response to Imatinib Mesylate in Patients with Gastrointestinal Stromal TumorAmerican Journal of Roentgenology, 2007
- We Should Desist Using RECIST, at Least in GISTJournal of Clinical Oncology, 2007
- Adrenocortical Carcinoma: Contrast Washout Characteristics on CTAmerican Journal of Roentgenology, 2006
- Pitfalls of Positive Findings in Staging Esophageal Cancer With F-18-Fluorodeoxyglucose Positron Emission TomographyAnnals of Surgical Oncology, 2003
- Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatisThe American Journal of Medicine, 1965